• Western blot analysis of the lysates from HeLa cells using SF3B3 antibody.
  • Western blot analysis of SF3B3 Antibody. The lane on the right is blocked with the SF3B3 peptide.

Anti-SF3B3 antibody (231-280 aa) (STJ95627)

SKU:
STJ95627

Current Stock:
Host: Rabbit
Applications: WB/ELISA/IHC
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Splicing factor 3B subunit 3 (231-280 aa) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
IHC-P 1:50-300
ELISA 2000-20000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SF3B3
Gene ID: 23450
Uniprot ID: SF3B3_HUMAN
Immunogen Region: 231-280 aa
Specificity: SF3b130 Polyclonal Antibody detects endogenous levels of SF3b130 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human SF3B3 at the amino acid range 231-280
Protein Name Splicing Factor 3b Subunit 3
Pre-Mrna-Splicing Factor Sf3b 130 Kda Subunit
Sf3b130
Staf130
Spliceosome-Associated Protein 130
Sap 130
Database Links Reactome: R-HSA-72163
Reactome: R-HSA-72165
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Splicing Factor 3b Subunit 3 antibody
Anti-Pre-Mrna-Splicing Factor Sf3b 130 Kda Subunit antibody
Anti-Sf3b130 antibody
Anti-Staf130 antibody
Anti-Spliceosome-Associated Protein 130 antibody
Anti-Sap 130 antibody
Anti-SF3B3 antibody
Anti-KIAA0017 antibody
Anti-SAP130 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance